K M C Speciality Hospitals (India) credit ratios

·Pharma & HealthChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendFY24Mar 2024FY23Mar 2023FY22Mar 2022FY21Mar 2021FY20 and earlierAlpha Plus
—39.926.925.7
FY20 and earlierEvery year the company has filed comes with Alpha Plus.
—1.1−6.38.0
—0.35×——
—0.01×——
—0.97×0.72×1.11×
—0.03×−0.17×0.35×
32.79×41.52×44.05×17.93×
—26.0%——
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

KMCSHIL₹149.36

K M C Speciality Hospitals (India) Limited

· Pharma & Health
₹ CrorePeersDRAGARWQKOVAILOTUSEYEGPTHEALTHGKSLSHALBYINDRAMEDCOARTEMISMEDMcap ₹2,439 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY21
31/03/2021
FY22
31/03/2022
FY23
31/03/2023
FY24
31/03/2024
Total Debt25.726.939.9—
Net Debt8.0-6.31.1—
Total Debt/Equity——0.35—
Net Debt/Equity——0.01—
Total Debt/EBITDA1.110.720.97—
Net Debt/EBITDA0.35-0.170.03—
Interest Coverage (EBIT/Interest)17.9344.0541.5232.79
Total Debt/Total Capital %——26.00—
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY24 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.